INDV

Indivior Pharmaceuticals Inc

Healthcare›Drug Manufacturers - Specialty & Generic|NASDAQ Global Select|US

Price

$30.47

Market Cap

$3.80B

Beta

1.19

P/E

19.4

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+4.29%

EPS Growth (YoY)+500.00%

Revenue CAGR 3Y+11.19%

P/E Ratio19.4

PEG Ratio0.04

FCF Yield-2.25%

Debt / Equity0.00

Interest Coverage6.7x

No credit card required

Already have an account? Sign in to view the full analysis for INDV.